Both dopamine and the putative dopamine D3 receptor antagonist PNU- 99194A induce a biphasic inhibition of phorbol ester-stimulated arachidonic acid release from CHO cells transfected with the dopamine D3 receptor

Life Sciences

Volumn 64, Issue 11, 1999, Pages 939-951

  Nilsson, Christer L ^a   Hellstrand, Monika ^a   Ekman, Agneta ^a   Eriksson, Elias ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Arachidonic acid; CHO cells; Dopamine; Dopamine D3 receptors; Phorbol ester; PNU 99194A; TPA; U 99194A

Indexed keywords

5,6 DIMETHOXY 2 (DIPROPYLAMINO)INDAN; ARACHIDONIC ACID; COMPLEMENTARY DNA; DOPAMINE; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; HALOPERIDOL; PERTUSSIS TOXIN; PHORBOL ESTER; PROTEIN KINASE C ACTIVATOR; UNCLASSIFIED DRUG;

ARACHIDONIC ACID METABOLISM; ARTICLE; BINDING AFFINITY; CHO CELL; DOPAMINERGIC SYSTEM; ENZYME ACTIVATION; FEMALE; LIGAND BINDING; LIMBIC CORTEX; METABOLIC ACTIVATION; METABOLIC INHIBITION; NEGATIVE FEEDBACK; NONHUMAN; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; REGULATORY MECHANISM;

ANIMALS; ARACHIDONIC ACID; CHO CELLS; CRICETINAE; DOPAMINE; DOPAMINE ANTAGONISTS; INDANS; PERTUSSIS TOXIN; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION; VIRULENCE FACTORS, BORDETELLA;

CRICETINAE; CRICETULUS GRISEUS;

EID: 0033525217     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00020-X     Document Type: Article

References (55)

1. P. Sokoloff, M.-P. Martres, B. Giros, M.-L. Bouthenet and J.-C. Schwartz. Biochem. Pharmacol. 43 659-666 (1992).
2. P. Sokoloff and J.-C. Schwartz. Trends Pharmacol. Sci. 16 270-275 (1995).
3. B. Levant. Pharmacol. Rev. 49 231-252 (1997).
4. S.B. Caine and G.F. Koob. Science 260 1814-1816 (1993).
5. C.L. Chio, M.E. Lajiness and R.M. Huff. Mol. Pharmacol. 45 51-60 (1994).
6. C. Pilon, D. Lévesque, V. Dimitriadou, N. Griffon, M.-P. Martres, J.-C. Schwartz and P. Sokoloff. Eur. J. Pharmacol. [Mol. Pharmacol. Sect.] 268 129-139 (1994).
7. B.A. Cox, M.P. Rosser, M.R. Kozlowski, K.M. Duwe, R.L. Neve and K.A. Neve. Synapse 21 1-9 (1995).
8. G.R. Seabrook, S. Patel, R. Marwood, F. Emms, M.R. Knowles, S.B. Freedman and G. McAllister. FEBS Lett. 312 123-126 (1992).
9. S. Patel, R. Marwood, F.A. Emms, M.R. Knowles, G. McAllister and S.B. Freedman. Brit. J. Pharmacol. 107 (suppl), 297P (1992).
10. J.E. Lachowitz and D.R. Sibley. Biochem. Biophys. Res. Comm. 237 394-399 (1997).
11. P. Falardeau, D. Godinot, B. Giros, J.-C. Schwartz and M. Caron. Soc. Neurosci. Abstr. 17 356 (149.7) (1991).
12. B. Gardner, D.A. Hall and P.G. Strange. Brit. J. Pharmacol. 118 1544-1559 (1996).
13. C.C. Felder, H.L. Williams and J. Axelrod. Proc. Natl. Acad. Sci. USA 88 6477-6480 (1991).
14. R.Y. Kanterman, L.C. Mahan, E.M. Briley, F.J. Monsma, Jr, D.R. Sibley, J. Axelrod and C.C. Felder. Mol. Pharmacol. 39 364-369 (1991).
15. D. Piomelli, C. Pilon, B. Giros, P. Sokoloff, M. Martres and J.-C. Schwartz. Nature 353 164-167 (1991).
16. V. Di Marzo, D. Vial, P. Sokoloff, J.-C. Schwartz and D. Piomelli. J. Neurosci. 13 4846-4853 (1993).
17. G. McAllister, M.R. Knowles, S. Patel, R. Marwood, F. Emms, G.R. Seabrook, M. Graziano, D. Borkowski, P.J. Hey and S.B. Freedman. FEBS. Lett. 324 81-86 (1993).
18. D. Vial and D. Piomelli. J. Neurochem. 64 2765-2772 (1995).
19. S.B. Freedman, S. Patel, R. Marwood, F. Emms, G.R. Seabrook, M.R. Knowles and G. McAllister. J. Pharmacol. Exp. Ther. 268 417-426 (1994).
20. R.G. MacKenzie, D. Van Leeuwen, T.A. Pugsley, Y.-H. Shih, S. Demattos, L. Tang, R.D. Todd and K.L. O'Malley. Eur. J. Pharmacol. [Mol. Pharmacol. Sect.] 266 79-85 (1994).
21. N. Waters, K. Svensson, S.R. Haadsma-Svensson, M.W. Smith and A. Carlsson. J. Neural Transm. [Gen. Sect.] 94 11-19 (1993).
22. A. Carlsson. Schizophrenia, S. Hirsch and D. Weinberger (Eds), 379-400, Blackwell, Oxford (1996).
23. V.H. Sethy, B.R. Ellerbrock, G.J. Fici and H. Wu. Brain Res. 733 41-45 (1996).
24. A. De Léan, P.J. Munson and D. Rodbard. Am. J. Physiol. 235 E97-E102 (1978).
25. A.E. Reifel-Miller, D.M. Conarty, K.M. Valasek, P.W. Iversen, D.J. Burns and K.A. Birch. J. Biol. Chem. 271 21666-21671 (1996).
26. A.M. Judd, I.S. Login and R.M. MacLeod. Endocrinol. 125 1134-1141 (1989).
27. R.O. Carlson and I.B. Levitan. J. Membr. Biol. 116 249-169 (1990).
28. V. Di Marzo, Prostaglandins, Leukotrienes and Fatty Acids 53 239-254 (1995).
29. N. Leidenheimer, S.J. McQuilkin, L.D. Hahner, P. Whiting and R. Adron Harris. Mol. Pharmacol. 41 1116-1123 (1992).
30. S. Jackowski. J. Biol. Chem. 271 20219-20222 (1996).
31. P. Sokoloff, M. Andrieux, R. Besançon, C. Pilon, M.-P. Martres, B. Giros and J.-C. Schwartz. Eur. J. Pharmacol. [Mol. Pharmacol. Sect.] 225 331-337 (1992).
32. S.W. Robinson, K.R. Jarvie and M.G. Caron. Mol. Pharmacol. 46 352-356 (1994).
33. S.W. Castro and P.G. Strange. FEBS Lett. 315 223-226 (1993).
34. K. Svensson, A. Carlsson, R.M. Huff, T. Kling-Petersen and N. Waters. Eur. J. Pharmacol. 263 235-243 (1994).
35. J. Diaz, D. Levesque, N. Griffon, C.H. Lammers, M.P. Martres, P. Sokoloff and J.-C. Schwartz. Eur. J. Neurosci. 6 1384-1387 (1994).
36. N. Waters, L. Löfberg, S. Haadsma-Svensson, K. Svensson, C. Sonesson and A. Carlsson. J. Neural Transm. [Gen. Sect.] 98 39-55 (1994).
37. K.M. Merchant, L.M. Figur and D.L. Evans. Cereb. Cortex 6 561-570 (1996).
38. S. Sigala, C. Missale and P.-F. Spano. Eur. J. Pharmacol. 336 107-112 (1997).
39. W.J. Watts and K.A. Neve. Mol. Pharmacol. 52 181-186 (1997).
40. R. Murray-Whelan, J.D. Reid, I. Piuz, M. Hezareh and W. Schlegel. Eur. J. Biochem. 230 164-169 (1995).
41. S. Offermanns, Y.-H. Hu and M.I. Simon. J. Biol. Chem. 271 26044-26048 (1996).
42. J.M. Lowndes, S.K. Gupta, S. Osawa and G.L. Johnson. J. Biol. Chem. 266 14193-14197 (1991).
43. W. Cho, L.P. Taylor, A. Mansour and H. Akil. J. Neurochem. 65 2105-2115 (1995).
44. S.B. Jones, S.P. Halenda and D.B. Bylund. Mol. Pharmacol. 39 239-245 (1991).
45. M.G. Eason, H. Kurose, B.D. Holt, J.R. Raymond and S.B. Liggett. J. Biol. Chem. 267 15795-15801 (1992).
46. S.V.P. Jones, C.J. Heilman and M.R. Brann. Mol. Pharmacol. 40 242-247 (1991).
47. N. Griffon, C. Pilon, F. Sautel, J.-C. Schwartz and P. Sokoloff. J. Neurochem. 68 1-9 (1997).
48. A.D. Federman, B.R. Conklin, K.A. Schrader, R.A. Reed and H.R. Bourne. Nature 356 159-161 (1992).
49. M.C. Peitsch, C. Borner and J. Tschopp. Trends Biol. Sci. 18 292-293 (1993).
50. J.D. Hildebrandt. Biochem. Pharmacol. 54 325-339 (1997).
51. Y. Tsunoda and C. Owyang. Biochem. Biophys. Res. Comm. 203 1716-1724 (1994).
52. S.W. Robinson and M.G. Caron. Mol. Pharmacol. 52 508-514 (1997).
53. A. Ekman. Thesis (Paper V), Göteborg University, Göteborg, Sweden (1996).
54. P.L. Gendreau, J.M. Petitto, R. Schnauss, K.J. Frantz, C. Van Hartesveldt, J.-L. Gariépy and M.H. Lewis. Eur. J. Pharmacol. 337 147-155 (1997).
55. N. Griffon, C. Pilon, J.-C. Schwartz and P. Sokoloff. Eur. J. Pharmacol. 282 R3-R4 (1995).